GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EMIS Group PLC (LSE:EMIS) » Definitions » Risk Assessment

EMIS Group (LSE:EMIS) Risk Assessment


View and export this data going back to 2010. Start your Free Trial

What is EMIS Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of EMIS Group is: No Data: Cannot be evaluated.


Competitive Comparison of EMIS Group's Risk Assessment

For the Health Information Services subindustry, EMIS Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EMIS Group's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EMIS Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where EMIS Group's Risk Assessment falls into.



EMIS Group  (LSE:EMIS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


EMIS Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of EMIS Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


EMIS Group (LSE:EMIS) Business Description

Traded in Other Exchanges
N/A
Address
Micklefield Lane, Fulford Grange, Rawdon, Leeds, GBR, LS19 6BA
EMIS Group PLC provides healthcare software and information technology services in the UK. The firm receives revenue from software licenses, hosting services, installation, training, and other support services. The company's main segments are Primary, Community and Acute Care, Community Pharmacy, and Patient. EMIS Group's community pharmacy software manages the dispensing process and keeps track of patient records and inventory.

EMIS Group (LSE:EMIS) Headlines

From GuruFocus

Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion

By Marketwired Marketwired 11-06-2020

ELIGEN B12 Receives “Amazon's Choice” Designation

By Marketwired Marketwired 05-30-2018

Emisphere Development Update

By Marketwired Marketwired 06-21-2018

Emisphere Development Update

By Marketwired Marketwired 05-31-2018

Emisphere Announces Leadership Changes

By Marketwired Marketwired 09-10-2019